S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro
about
Protein release through nonlethal oncotic pores as an alternative nonclassical secretory pathwayS100A13. Biochemical characterization and subcellular localization in different cell linesSoluble Jagged 1 represses the function of its transmembrane form to induce the formation of the Src-dependent chord-like phenotypeCopper induces the assembly of a multiprotein aggregate implicated in the release of fibroblast growth factor 1 in response to stressDirect and heterologous approaches to identify the LET-756/FGF interactomeFibroblast growth factor-1 interacts with the glucose-regulated protein GRP75/mortalinBinding of FGF-1 variants to protein kinase CK2 correlates with mitogenicity.Secretion without GolgiThe intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to exportStructure of calcium-bound human S100A13 at pH 7.5 at 1.8 Å resolutionThe Heterohexameric Complex Structure, a Component in the Non-classical Pathway for Fibroblast Growth Factor 1 (FGF1) SecretionAlternative splicing of synaptotagmins involving transmembrane exon skippingCysteine Oxidation Targets Peroxiredoxins 1 and 2 for Exosomal Release through a Novel Mechanism of Redox-Dependent SecretionAmlexanox Blocks the Interaction between S100A4 and Epidermal Growth Factor and Inhibits Cell ProliferationAmlexanox reversibly inhibits cell migration and proliferation and induces the Src-dependent disassembly of actin stress fibers in vitroA novel alternatively spliced variant of synaptotagmin VI lacking a transmembrane domain. Implications for distinct functions of the two isoformsA Network Map of FGF-1/FGFR Signaling System.Gene expression profiles in rat mesenteric lymph nodes upon supplementation with conjugated linoleic acid during gestation and sucklingA chemical screen identifies small molecules that regulate hepcidin expression.Transport of exogenous growth factors and cytokines to the cytosol and to the nucleus.Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis.Sphingosine kinase 1 is a critical component of the copper-dependent FGF1 export pathwayCrystallization and preliminary X-ray analysis of human S100A13.Calcium-dependent and -independent interactions of the S100 protein family.S100A13-lipid interactions-role in the non-classical release of the acidic fibroblast growth factorIntracellular and extracellular cytokine-like functions of prothymosin α: implications for the development of immunotherapies.Protein-phospholipid interactions in nonclassical protein secretion: problem and methods of study.Synaptotagmin-1 is required for fibroblast growth factor-1 release.Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims.Vesicle transmembrane potential is required for translocation to the cytosol of externally added FGF-1.Stress-induced non-vesicular release of prothymosin-α initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage.Olopatadine suppresses the migration of THP-1 monocytes induced by S100A12 protein.The nonclassic secretion of thioredoxin is not sensitive to redox state.The comparative release of FGF1 by hypoxia and temperature stress.The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor.S100 and cytokine expression in caries.Requirement of phosphatidylinositol 3-kinase activity for translocation of exogenous aFGF to the cytosol and nucleus.Notch activation suppresses fibroblast growth factor-dependent cellular transformation.S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro.The precursor but not the mature form of IL1alpha blocks the release of FGF1 in response to heat shock.
P2860
Q21284185-BB90EC2A-08CE-46D5-92C7-AB9F2D3107DFQ22253345-D4F009EC-AE7E-4810-AC17-E5FBA4370655Q24291369-F750D980-B657-43E7-9DDC-9DECEE20A3F2Q24291389-4D4FB623-03F7-40BD-B910-D8DF3C49944DQ24324037-667088AF-1479-48EE-98EF-8176C9E721F2Q24531847-AA3BFF42-AA01-46FF-B3B3-85CBA0569A96Q24534269-55BF0AE2-82B8-4666-99E6-B2FA524E7CB2Q24654691-AB834B58-AD0D-4B52-8107-8FEBF4AB01D4Q24673957-0AD96A93-B53F-46C5-9443-C76C57228DBDQ27649813-8275C761-1B33-45E1-9A16-9F9D8F1236B0Q27660174-405F4085-59B2-447C-985A-8E9D59F95C9BQ28137740-710D10BC-A091-40F8-ADAE-90FE39989CBFQ28257763-CAAFF5C9-2EDC-451A-9A79-9DE1D043CBA3Q28553734-E3913A7A-BDA3-43D8-AB93-9DFA761D9E60Q28568028-1EF3BD7D-F705-4801-BBAC-66F2364C2B86Q28584924-E79C14CB-0647-4899-A31E-4021A546F6A6Q33562967-19D0FFF3-A1B0-45CC-956B-D5DB52E0260EQ33868204-344A8CBC-7B02-4335-B6A5-C756C1C190E4Q34345426-5EF73C12-6687-4904-B433-2EA003A29D7FQ35035928-910EEE87-AEFE-49AF-82C5-6D0E3D5C1FA8Q35791685-29303BEA-D6BA-4F4C-A16F-F414EBD5704BQ36026708-1A06A84B-2548-4759-9E2A-12285411E2BAQ36426318-30C6B8D8-57B7-4770-8942-B1B8919CB84EQ36472950-C744C930-1713-4AF9-B77F-451886A14653Q37297726-C4E7A828-A9DD-4004-AB7F-8E04C5D70808Q37909411-C41A86E2-D9DB-4A01-9DBF-F6B5C2CE296CQ38080394-F4E2F935-D912-4860-976A-B1AE247195F5Q38334213-5891B1E4-11DA-4D82-8102-8100719F1D57Q38515882-BD424523-E9D5-4BB3-A78A-673DAC655746Q39648002-FA578269-05F9-4446-9ACE-13243C1C51D7Q39704112-86E7783F-B515-4062-B683-D9EE454A39B9Q40251926-A09C03FE-FE63-4605-855E-E00FC37BB2B5Q40677508-73FE3C29-4135-4AFA-92F0-15E73BBAC43BQ40784197-D3F5CE39-F2A5-4C13-848E-468FC3E3EF58Q40787009-B0E64C47-BB15-4494-ADB7-8630F347DDCEQ40936329-88F474F4-34D4-4EAD-AB51-E39BDDE43389Q42803242-2B42F014-9D17-4A5D-A438-9935BC2330D3Q42804897-F0AE6F4E-00CD-4458-B145-80340F176A02Q42827961-C9ABFF02-0066-4356-B6C7-CBAA3B0FDCD6Q42833929-A6B25DA6-785F-44BA-A225-B8DFE78EEB42
P2860
S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
S100A13 is involved in the reg ...... naptotagmin-1 release in vitro
@ast
S100A13 is involved in the reg ...... naptotagmin-1 release in vitro
@en
S100A13 is involved in the reg ...... naptotagmin-1 release in vitro
@nl
type
label
S100A13 is involved in the reg ...... naptotagmin-1 release in vitro
@ast
S100A13 is involved in the reg ...... naptotagmin-1 release in vitro
@en
S100A13 is involved in the reg ...... naptotagmin-1 release in vitro
@nl
prefLabel
S100A13 is involved in the reg ...... naptotagmin-1 release in vitro
@ast
S100A13 is involved in the reg ...... naptotagmin-1 release in vitro
@en
S100A13 is involved in the reg ...... naptotagmin-1 release in vitro
@nl
P2093
P2860
P3181
P356
P1476
S100A13 is involved in the reg ...... naptotagmin-1 release in vitro
@en
P2093
C Mouta Carreira
F Tarantini
J T Lathrop
T M LaVallee
W H Burgess
P2860
P304
22224-22231
P3181
P356
10.1074/JBC.273.35.22224
P407
P577
1998-08-01T00:00:00Z